Neurofibromatosis type 2
- PMID: 11106352
- PMCID: PMC1734496
- DOI: 10.1136/jmg.37.12.897
Neurofibromatosis type 2
Erratum in
- J Med Genet 2001 Oct;38(10):727a
Abstract
Neurofibromatosis type 2 is an often devastating autosomal dominant disorder which, until relatively recently, was confused with its more common namesake neurofibromatosis type 1. Subjects who inherit a mutated allele of the NF2 gene inevitably develop schwannomas, affecting particularly the superior vestibular branch of the 8th cranial nerve, usually bilaterally. Meningiomas and other benign central nervous system tumours such as ependymomas are other common features. Much of the morbidity from these tumours results from their treatment. It is now possible to identify the NF2 mutation in most families, although about 20% of apparently sporadic cases are actually mosaic for their mutation. As a classical tumour suppressor, inactivation of the NF2 gene product, merlin/schwannomin, leads to the development of both NF2 associated and sporadic tumours. Merlin/schwannomin associates with proteins at the cell cytoskeleton near the plasma membrane and it inhibits cell proliferation, adhesion, and migration.
Similar articles
-
[Neurofibromatosis type 2].Acta Otorrinolaringol Esp. 2010 Jul-Aug;61(4):306-11. doi: 10.1016/j.otorri.2009.12.005. Epub 2010 Feb 6. Acta Otorrinolaringol Esp. 2010. PMID: 20138250 Review. Spanish.
-
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.Acta Otorhinolaryngol Ital. 2016 Oct;36(5):345-367. doi: 10.14639/0392-100X-1093. Acta Otorhinolaryngol Ital. 2016. PMID: 27958595 Free PMC article. Review.
-
Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.Semin Pediatr Neurol. 2015 Dec;22(4):240-58. doi: 10.1016/j.spen.2015.10.008. Epub 2015 Oct 28. Semin Pediatr Neurol. 2015. PMID: 26706012 Review.
-
[Neurofibromatosis type 2 (central neurofibromatosis or bilateral acoustic neuromas, vestibular schwannomas): from phenotype to gene].Lijec Vjesn. 2006 Sep-Oct;128(9-10):309-16. Lijec Vjesn. 2006. PMID: 17128670 Review. Croatian.
-
Neurofibromatosis type 2 (NF2): a clinical and molecular review.Orphanet J Rare Dis. 2009 Jun 19;4:16. doi: 10.1186/1750-1172-4-16. Orphanet J Rare Dis. 2009. PMID: 19545378 Free PMC article. Review.
Cited by
-
Microdeletion del(22)(q12.2) encompassing the facial development-associated gene, MN1 (meningioma 1) in a child with Pierre-Robin sequence (including cleft palate) and neurofibromatosis 2 (NF2): a case report and review of the literature.BMC Med Genet. 2012 Mar 22;13:19. doi: 10.1186/1471-2350-13-19. BMC Med Genet. 2012. PMID: 22436304 Free PMC article. Review.
-
HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins.Oncogene. 2007 Jul 19;26(33):4825-32. doi: 10.1038/sj.onc.1210282. Epub 2007 Feb 12. Oncogene. 2007. PMID: 17297447 Free PMC article.
-
Challenges in Anaesthetic Management in a Case of Facial Plexiform Neurofibromatosis Posted for Debulking Surgery.Cureus. 2023 Jan 30;15(1):e34406. doi: 10.7759/cureus.34406. eCollection 2023 Jan. Cureus. 2023. PMID: 36874697 Free PMC article.
-
Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32.PLoS One. 2013 Jun 11;8(6):e65868. doi: 10.1371/journal.pone.0065868. Print 2013. PLoS One. 2013. PMID: 23776562 Free PMC article.
-
Cutaneous plexiform schwannomas in a patient with neurofibromatosis type 2.Ann Dermatol. 2009 Nov;21(4):402-5. doi: 10.5021/ad.2009.21.4.402. Epub 2009 Nov 30. Ann Dermatol. 2009. PMID: 20523833 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous